ClinicalTrials.gov
public full text
Public Domain
Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
This multicenter, post-marketing, observational study will evaluate quality of life in participants with Idiopathic Pulmonary Fibrosis (IPF) under treatment with pirfenidone (Esbriet).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis#1152819
- Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF#1308515
- Is pirfenidone effective for idiopathic pulmonary fibrosis?#292970
- Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF#893250
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis#1259632
Record · ID 1183107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive